US Pharma MarketingThe post FDA clears Deep Reasoning AI’s NeuroDR for neurovascular CT scans appeared first on Medical Device Network.
FDA clears Deep Reasoning AI’s NeuroDR for neurovascular CT scans
The US FDA has granted 510(k) clearance for Deep Reasoning AI’s NeuroDR, an AI software tool designed for neurovas CTA scans. The clearance was secured 105 days after submission, with Deep Reasoning AI now planning to supply the platform in the US. NeuroDR operates automatically in the background after a scan finishes. Credit: Aleksandar Malivuk / Shutterstock.com. The US Food and Drug Administration (FDA) has granted 510(k) clearance (K262134) for Deep Reasoning AI’s NeuroDR, an AI software tool designed for neurovascular computed tomography angiography scans. The software visualises head and neck arteries using these scans. Artificial Intelligence in Medical Devices:…
The US FDA has granted 510(k) clearance for Deep Reasoning AI’s NeuroDR, an AI software tool designed for neurovas CTA scans.
Source: Medical Device Network